These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 668055)

  • 1. Enhancement of platelet aggregation by tranylcypromine in mouse cerebral microvessels.
    Rosenblum WI; El-Sabban F
    Circ Res; 1978 Aug; 43(2):238-41. PubMed ID: 668055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iproniazid inhibits platelet aggregation in mesenteric microvessels.
    Rosenblum WI; el-Sabban F
    Blood Vessels; 1980; 17(6):324-6. PubMed ID: 7437524
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of tranylcypromine on levels of 6-keto-PGF1 alpha and other prostaglandins in brain and mesentery of the mouse.
    Ellis EF; Rosenblum WI; Birkle DL; Wright KF; Traweek DL; Saady JJ; Choi SC
    Artery; 1982; 10(6):454-64. PubMed ID: 6961890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 14,15-Epoxyeicosatrienoic acid inhibits platelet aggregation in mouse cerebral arterioles.
    Heizer ML; McKinney JS; Ellis EF
    Stroke; 1991 Nov; 22(11):1389-93. PubMed ID: 1750047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoamine oxidase inhibiting properties of SU-11,739 in the rat. Comparison with pargyline, tranylcypromine and iproniazid.
    Maître L
    J Pharmacol Exp Ther; 1967 Jul; 157(1):81-8. PubMed ID: 6029494
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of iprazid and transamine on cerebral circulation and the concentrations of gamma-aminobutyric, glutamic and aspartic acids in the tissues of the walls of the cerebral vessels].
    Mirzoian SA; Paglavian VG
    Farmakol Toksikol; 1972; 35(6):698-700. PubMed ID: 4651803
    [No Abstract]   [Full Text] [Related]  

  • 7. The interaction between monoamine oxidase inhibitors and narcotic analgesics in mice.
    Rogers KJ; Thornton JA
    Br J Pharmacol; 1969 Jul; 36(3):470-80. PubMed ID: 5789805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apropos of the mechanism of action of monoamine oxidase-inhibitors on the coronary circulation].
    Mirzoian RS
    Farmakol Toksikol; 1965; 28(1):51-5. PubMed ID: 5845043
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of OKY-1581, a thromboxane synthesis inhibitor, on the platelet aggregation and vasodilation induced by injury of mouse pial arterioles.
    Rosenblum WI; El-Sabban F
    J Cereb Blood Flow Metab; 1983 Mar; 3(1):122-6. PubMed ID: 6681612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiordiazepoxide and monoamine oxidase inhibitors on avoidance behaviour in mice.
    Sansone
    Pharmacol Res Commun; 1977 Sep; 9(8):729-35. PubMed ID: 928500
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative activity of some inhibitors of mono-amine oxidase in potentiating the action of tryptamine in vitro and in vivo.
    MAXWELL DR; GRAY WR; TAYLOR EM
    Br J Pharmacol Chemother; 1961 Dec; 17(3):310-20. PubMed ID: 14471627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants alleviate nicotine-induced platelet aggregation in cerebral arterioles of mice in vivo.
    Fahim MA; Nemmar A; Singh S; Hassan MY
    Physiol Res; 2011; 60(4):695-700. PubMed ID: 21574756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin delays platelet aggregation after injury of cerebral arterioles.
    Rosenblum WI; el-Sabban F; Hirsh PD
    Stroke; 1986; 17(6):1203-5. PubMed ID: 3810722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of iprazid and transamine on monoamine oxidase activity and monoamine content on the brain of dogs and rabbits].
    Kocherga VI; Gotovtseva EP
    Ukr Biokhim Zh; 1967; 39(2):125-9. PubMed ID: 5603055
    [No Abstract]   [Full Text] [Related]  

  • 15. [Behavioral modifications observed following repeated administrations of monoamine oxidase inhibitors].
    Goldwurm GF; Torrigiani G
    Riv Neurobiol; 1964; 10(4):Suppl:1099-106. PubMed ID: 5827089
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoamine oxidase inhibitors and histamine metabolism.
    Benedetti MS; Ancher JF; Sontag N
    Experientia; 1980 Jul; 36(7):818-10. PubMed ID: 6772465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the action of monoamine oxidase inhibitors on the noradrenaline uptake system and their antidepressant efficacy.
    Hendley ED; Snyder SH
    Nature; 1968 Dec; 220(5174):1330-1. PubMed ID: 5701350
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
    Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
    J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of trans-2-cyclohexyloxycyclopropylamine and derivatives.
    Finkelstein J; Chiang E; Vane FM; Lee J
    J Med Chem; 1966 May; 9(3):319-23. PubMed ID: 5960896
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of monoamine oxidase inhibitors on qualitative alterations in enzymatic properties of mitochondrial monoamine oxidases.
    Abdel Samed MH; Akopyan ZI; Veryovkina IV; Kulygina AA; Gorkin VZ
    Biochem Pharmacol; 1971 Oct; 20(10):2571-7. PubMed ID: 5114498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.